How to cite item

First-line immune-chemotherapy combination: the right strategy to fight squamous non-small cell lung cancer?

   
@article{TLCR28462,
	author = {Francesco Passiglia and Paolo Bironzo and Giorgio V. Scagliotti},
	title = {First-line immune-chemotherapy combination: the right strategy to fight squamous non-small cell lung cancer?},
	journal = {Translational Lung Cancer Research},
	volume = {8},
	number = {4},
	year = {2019},
	keywords = {},
	abstract = {In The New England Journal of Medicine, Paz-Ares and colleagues published the results of KEYNOTE-407, a randomized phase III placebo-controlled trial, investigating the addition of pembrolizumab or placebo to first-line carboplatin-taxane chemotherapy, in patients with advanced squamous non-small cell lung cancer (NSCLC) (1). The study met its co-primary end-points, since immune-chemotherapy combination led to a significant longer overall survival (OS) and progression-free survival (PFS) as compared to placebo combination.},
	issn = {2226-4477},	url = {https://tlcr.amegroups.org/article/view/28462}
}